Abstract:
ASP-1 polypeptides and polynucleotides and methods for producing such polypeptides by recombinant techniques are disclosed. Also disclosed are methods for utilizing ASP-1 polypeptides and polynucleotides in the design of protocols for the treatment of obesity, cardiovascular disorders such as hypertension and arteriosclerosis, diabetes, hypo- and hyperglycemia and anorexia, among others, and diagnostic assays for such conditions.
Abstract:
The present invention relates to the use of lipophilic diesters of the chelating agent 1,2-bis(2 aminophenoxy)ethane-N,N,N’,N’-tetraacetic acid (BAPTA) for preventing, treating or managing atherosclerosis, amyloidosis-related diseases and disorders and other pathologies associated with proteins aggregations. In particular, these compounds are useful in treating cardiac and vascular amyloidosis, neurodegenerative diseases and disorders and cerebral amyloid angiopathy (CAA).
Abstract:
Pyrimidine derivatives are ubiquitination inhibitors that inhibit the ubiquitin ligase activity, particularly of POSH polypeptides, are useful for the treatment of viral infections and neurological disorders.
Abstract:
The present invention relates to the use of lipophilic diesters of the chelating agent 1,2-bis(2 aminophenoxy)ethane-N,N,N',N'-tetraacetic acid (BAPTA) for preventing, treating or managing atherosclerosis, amyloidosis-related diseases and disorders and other pathologies associated with proteins aggregations. In particular, these compounds are useful in treating cardiac and vascular amyloidosis, neurodegenerative diseases and disorders and cerebral amyloid angiopathy (CAA).
Abstract:
An embodiment of the invention provides a use of an effective amount of a transition metal complex of a corrole, an optically active isomer thereof, or a pharmaceutically acceptable salt thereof for treating a disease of the eye and/or the kidney in a subject suffering from diabetes. An embodiment of the invention further provides a use of a transition metal complex of a corrole, an optically active isomer thereof, or a pharmaceutically acceptable salt thereof for lowering serum glucose and serum triglyceride levels in a subject suffering from diabetes.
Abstract:
The invention concerns the use of a compound of formula (I) in which: R1 represents a hydrogen or halogen atom, such a chlorine or fluorine, a linear or branched C1-C4 alkyl or C1-C4 alkoxy group; R2, R3, and R4 represent, independently of one another, a hydrogen atom, a linear or branched C1-C4 alkyl group, or a C3-C4 cycloalkyl group; and R5 represents a hydrogen atom, a C1-C2 alkyl, C1-C2 fluoroalkyl, or C1-C2 perfluoroalkyl group, for preparing a medicine useful for treating ejaculation disorders such as retrograde ejaculation or aspermia.
Abstract:
The present invention relates to methods for treatment, prevention, and inhibition of progression of Alzheimer's disease, and other brain diseases characterized by amyloid plaque deposits, comprising the administration to a subject a bile acid fatty acid conjugates or bile salt fatty acid conjugate (FABAC).
Abstract:
Pyrimidine derivatives are ubiquitination inhibitors that inhibit the ubiquitin ligase activity, particularly of POSH polypeptides, are useful for the treatment of viral infections and neurological disorders.